Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Semb

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Annals of the Rheumatic Diseases|January 7, 2014
Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritisE E A Arts, C Popa, A A Den Broeder, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|September 1, 1992
A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 4. Assessment of nasolabial appearanceC Asher-McDade, V Brattström, E Dahl, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|September 1, 1992
A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 1. Principles and study designW C Shaw, C Asher-McDade, V Brattström, et al.
Journal of the American College of Cardiology|May 14, 2003
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery diseaseTorgun Waehre, Jan K Damås, Lars Gullestad, et al.
Journal of Internal Medicine|July 25, 2007
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery diseaseØ Bleie, A G Semb, H Grundt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases StudyS Rollefstad, E Ikdahl, J Hisdal, et al.
European Journal of Clinical Investigation|March 2, 2006
Increased inflammatory markers in children with familial hypercholesterolaemiaT Ueland, M N Vissers, A Wiegman, et al.
Scandinavian Journal of Rheumatology|March 11, 2015
Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative studyS H Sveaas, I J Berg, S A Provan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2005
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTESKirsten B Holven, Jan K Damås, Arne Yndestad, et al.
Journal of the American College of Cardiology|January 22, 2003
Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapyAnne G Semb, Sanne van Wissen, Thor Ueland, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Annals of the Rheumatic Diseases|January 7, 2014
Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritisE E A Arts, C Popa, A A Den Broeder, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|September 1, 1992
A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 4. Assessment of nasolabial appearanceC Asher-McDade, V Brattström, E Dahl, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|September 1, 1992
A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 1. Principles and study designW C Shaw, C Asher-McDade, V Brattström, et al.
Journal of the American College of Cardiology|May 14, 2003
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery diseaseTorgun Waehre, Jan K Damås, Lars Gullestad, et al.
Journal of Internal Medicine|July 25, 2007
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery diseaseØ Bleie, A G Semb, H Grundt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases StudyS Rollefstad, E Ikdahl, J Hisdal, et al.
European Journal of Clinical Investigation|March 2, 2006
Increased inflammatory markers in children with familial hypercholesterolaemiaT Ueland, M N Vissers, A Wiegman, et al.
Scandinavian Journal of Rheumatology|March 11, 2015
Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative studyS H Sveaas, I J Berg, S A Provan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2005
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTESKirsten B Holven, Jan K Damås, Arne Yndestad, et al.
Journal of the American College of Cardiology|January 22, 2003
Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapyAnne G Semb, Sanne van Wissen, Thor Ueland, et al.
Pageof 16